Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Bright Minds Biosciences to Present at the Benzinga Global Small Cap Conference | ||||||||
By: GlobeNewswire - 11 May 2021 | Back to overview list |
|||||||
VANCOUVER, British Columbia, May 11, 2021 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (CSE:DRUG), a biotechnology company focused on developing novel transformative treatments for neuropsychiatry disorders, epilepsy and pain, today announced that Ian McDonald, Chief Executive Officer, and Dr. Gideon Shapiro Ph.D, Vice President of Discovery, will be presenting at the Benzinga Global Small Cap Conference as follows:
The presentation will be webcast live at the aforementioned time and available for 7 days thereafter using the link provided above. About Bright Minds Investor Contact: |
||||||||
|
||||||||
Copyright 2021 GlobeNewswire | Back to overview list |